Transcription of major histocompatibility complex (MHC) class II genes is controlled largely by the conserved promoter elements called the X and Y boxes. We show here that RFX, the X box-binding protein deficient in certain MHC class IH-deficient immunodeficiency patients (CmD), and the Y box-binding protein NF-Y Despite extensive analysis of MHC class II promoter elements and their cognate DNA-binding proteins (2, 3, 6), the molecular mechanisms controlling transcription of MHC class II genes remain elusive. The MHC class II promoter appears to function as a single unit for which it has proved difficult to dissociate and define the roles of the individual sequence elements and factors. The Z, X, X2, and Y boxes all contribute to both B-cell specific and interferon y-induced expression (21) (22) (23) , and neither of these two modes of expression can be unequivocally attributed to any one of the identified DNA-binding proteins. This suggests that transcription of MHC class II genes is strongly dependent on cooperation of factors binding to the various promoter elements.
The human major histocompatibility complex (MHC) class II genes encode the a and 8 chains of the HLA-DR, -DQ, and -DP class II molecules which present processed exogenous antigens to CD4+ T lymphocytes. Precise regulation of MHC class II gene expression is crucial to the immune response, as demonstrated by the fact that aberrant expression is associated with immune dysfunction (1) . MHC class II genes are expressed constitutively in only a limited number of cells, including B lymphocytes, macrophages, dendritic cells, thymic epithelial cells, and activated T lymphocytes (2, 3) . Their expression can be modulated or induced by a variety of stimuli (2, 3) , of which the most potent is interferon y (4, 5) .
All MHC class II promoters share conserved sequence motifs referred to as the Z (also called W, H, or S), X, X2, and Y boxes (2, 3, 6) . Nuclear factors binding to these sequences have been identified and some of them have been cloned. The Y box is the target of the ubiquitously expressed heterodimeric CCAAT-binding protein NF-Y (7, 8) . The X2 box is in fact a cAMP response element (CRE)-or tetradecanoylphorbol acetate response element (TRE)-like sequence and is recognized by members of the Jun/Fos and CREB/ATF families of transcription factors (9) (10) (11) (12) . Proteins binding to the X box include members of a family of DNAbinding proteins called RFX1 to RFX4, which probably correspond to the nuclear NF-X, EP, MDBP, or EF-C complexes (refs. [13] [14] [15] [16] [17] and unpublished work), and an as yet uncloned nuclear protein called RFX (16, 18) . RFX is of particular interest because its binding is deficient in B-cell lines derived from certain patients suffering from MHC class II-deficient immunodeficiency (CID), a disease due to a
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
regulatory defect in the expression of MHC class II genes (18) (19) (20) .
Despite extensive analysis of MHC class II promoter elements and their cognate DNA-binding proteins (2, 3, 6) , the molecular mechanisms controlling transcription of MHC class II genes remain elusive. The MHC class II promoter appears to function as a single unit for which it has proved difficult to dissociate and define the roles of the individual sequence elements and factors. The Z, X, X2, and Y boxes all contribute to both B-cell specific and interferon y-induced expression (21) (22) (23) , and neither of these two modes of expression can be unequivocally attributed to any one of the identified DNA-binding proteins. This suggests that transcription of MHC class II genes is strongly dependent on cooperation of factors binding to the various promoter elements.
In other systems, cooperation between transcription factors has been shown to occur indirectly at the level of transcription activation by synergistic interactions with the basal transcription machinery (24) (25) (26) or directly at the level of DNA binding (27, 28) . Several observations suggest that cooperative binding might play a key role in the MHC class II system. The spatial arrangement of the Z, X, X2, and Y boxes is strongly conserved (2, 3, 6) , suggesting that there are constraints imposed on the proteins binding to these sequences. This is supported by the fact that correct spacing of the Z, X, and Y elements is crucial for promoter function (29, 30) . A third line of evidence comes from the study of CID B-cell lines exhibiting a defect in RFX binding activity (16, 18, 20, 31) . Although in vitro this binding defect is highly specific for RFX and does not affect NF-Y or X2 binding proteins (16, 18, 20, 31) , the entire promoter, including the X, X2, and Y boxes, is unoccupied in vivo (32 Proc. Natl. Acad. Sci. USA 91 (1994) 555 to construct all DRA promoter mutants (Fig. 1) . To construct the Ml, M2, M3, M4, X2M, +5 and, +10 mutants, mutated double-stranded oligonucleotides were inserted between the Apa I and Xho I sites of pDRsyn. To construct the -5, -10, and -17 mutants, pDRsyn was linearized with Xho I, treated with BAL-31 exonuclease, and religated.
Electrophoretic Mobility-Shift Assays. Mobility-shift assays were performed as described (13, 14, 18) (34) . This methylated sequence is an efficient target site for NF-X and the cloned X box-binding factors but is not bound by RFX (ref. 17 Robert or fresh B lymphocytes as described (16, 18 
RESULTS
Binding of RFX and NF-Y Is Cooperative. Electrophoretic mobility-shift assays were performed with B-cell nuclear extracts and an oligonucleotide (DRA XY) containing the X and Y boxes of the HLA-DRA promoter (Fig. 1) . Binding conditions were optimized by the addition of competitor oligonucleotides to allow binding of either RFX alone, NF-Y alone, or both RFX and NF-Y (see Materials and Methods). Three distinct complexes were formed with the DRA XY probe when both RFX and NF-Y were allowed to bind (Fig.  2) . The lower complex corresponded to NF-Y, as it was eliminated by a Y-box competitor oligonucleotide ( Fig. 2A) and was supershifted by an NF-Y antiserum (Fig. 2B) by an X-box competitor and was not formed in a CID extract in which RFX was deficient ( Fig. 2A) . The upper band contained both RFX and NF-Y; it was eliminated by both Y-box and X-box competitor oligonucleotides ( Fig. 2A) , was not formed in the CID extract ( Fig. 2A) , and was supershifted by the NF-Y antiserum (Fig. 2B) . The RFX/NF-Y complex was clearly the most abundant, suggesting cooperative binding of RFX and NF-Y. To confirm this, binding of RFX alone, NF-Y alone, and RFX and NFY together was studied as a function of protein concentration (Fig. 3) . At all protein concentrations, the fraction of probe bound by the RFX/NF-Y complex (XY in Fig. 3B ) was -5-fold greater than would be expected if binding of RFX and NF-Y were independent events (XY exp. in Fig. 3B) . Moreover, in the presence of NF-Y, the total fraction of probe bound by RFX was increased by a factor of 2 with respect to conditions under which only RFX was allowed to bind (compare X and X + XY in Fig. 3B) . Similarly, the total amount of probe bound by NF-Y was increased by a factor of 1. Analysis of dissociation rates demonstrated that the RFX/ NF-Y/DNA complex was more stable than both the RFX and the NF-Y complexes (Fig. 4 B and C) . The half life of the RFX-DNA interaction was increased 50 fold by NF-Y. The half-life of the NF-Y-DNA interaction was doubled by RFX. Cooperative binding thus stabilized the interaction of both RFX and NF-Y with their target sites.
X2-Binding Proteins Are Not Involved in RFX/NF-Y Complex Formation. To exclude a role of X2-binding proteins in the RFX/NF-Y interaction we examined the formation and stability of the RFX/NF-Y complex on a DRA XY oligonucleotide containing a mutated X2 box (X2M in Fig. 1) . The RFX/NF-Y complex formed on X2M was indistinguishable from that formed on the wild-type probe in terms of efficiency of complex formation, mobility in the gel, and dissociation rate (Fig. 4D) .
Functional Role of RFX/NF-Y Complex Formation. To determine whether RFX/NF-Y complex formation was functionally important, four mutated DRA promoters were constructed ( Fig. 1 ) and analyzed both for promoter strength and for binding of factors to their X, X2, and Y boxes. Activity of the mutated promoters was analyzed in two systems, constitutive expression in the B-cell line Raji and interferon 'yinduced expression in the melanoma cell line ME1477. In both systems, the activity of the mutated promoters correlated with the efficiency of RFX/NF-Y complex formation rather than with binding of RFX, NF-Y, or AP1 on their own (Fig. 5) . Thus, the Ml mutation had no effect on either the RFX/NF-Y complex or promoter activity, whereas the M3 and M4 mutations completely eliminated both the RFX and the RFX/NF-Y complexes and led to a 10-to 20-fold reduction in promoter strength. More significantly, the M2 mutation, which led to an almost complete loss in binding of RFX on its own but to only a modest 30% reduction in the RFX/NF-Y complex, retained 40% of its expression in B cells and 70% of its inducibility by interferon y. This mutation is crucial because it permits a distinction between the strong reduction obtained by complete disruption of the cooperative RFX/NF-Y interaction (M3, M4) and the relatively modest effect of eliminating only the RFX-DNA interaction (M2). This suggests that activity of the HLA-DRA promoter is determined to a greater extent by the RFX/NF-Y interaction than by independent binding of the two proteins.
RFX/NF-Y Complex Formation Is Affected by X-Y Box
Spacing. Correct stereospecific alignment between the X and Y boxes is crucial for HLA-DRA promoter activity. For optimal activity, X-Y spacing must be an integral number of turns (multiples of 10 bp) of the DNA helix (29, 30) . We determined whether this requirement reflected the effect of X-Y box spacing on cooperative binding between RFX and NF-Y. DRA promoter mutations that modified the X-Y box spacing by one complete turn ( Fig. 1 ; -10 and +10 bp), by greater than one turn (-17 bp) or by a half turn (-5 and +5 bp) were analyzed for their activity in the B-cell line Raji (Fig.  6B ) and for their ability to support RFX/NF-Y complex formation (Fig. 6A) . The -17 mutation did not allow RFX and NF-Y to bind together, presumably as a result of steric hindrance, and, as expected, activity of the promoter was strongly reduced. The RFX/NF-Y complex was able to form on the -10, -5, +5, and +10 spacing mutants. However, these mutants differed in their ability to support RFX/NF-Y complex formation as assessed by its resistance to increasing salt concentration (Fig. 6A) . Dissociation rate analysis indicated that this difference reflected a difference in stability of the complex (data not shown). For the wild-type, -10, -5, and +5 constructs, stability of the RFX/NF-Y complex correlated remarkably well with activity ofthe promoter (Fig.  6C ). For the -10 mutant, stability of the RFX/NF-Y complex was unaffected and its activity was identical to that ofthe wild-type promoter. For the +5 and -5 mutants, stability of 1.4 3'I)5
the RFX/NF-Y complex was reduced and activity was only 20% of wild type. These results thus indeed suggest that stability of the RFX/NF-Y complex is determined by X-Y box spacing and is an important parameter determining promoter function. Interestingly, the +10 mutation distinguished itself from the other spacing mutants. It led to a reduction in RFX/NF-Y complex stability, yet activity ofthe promoter was increased. This particular mutation suggests that correct alignment between RFX and NF-Y may be more critical than stability of the RFX/NF-Y complex (Fig. 6C) .
DISCUSSION
Despite detailed analysis of the individual promoter elements and the proteins that bind to them (2, 3, 6) , little insight has been gained concerning the molecular mechanisms controlling MHC class II gene transcription. In particular, few studies have addressed the question of protein-protein interactions occurring between MHC class II promoter-binding proteins, although it is becoming clear that such interactions play a key role in determining the transcriptional activity of eukaryotic genes (24-28, 36, 37 Proc. Natl. Acad. Sci. USA 91 (1994) promoter activity with formation of the RFX/NF-Y complex rather than with binding of RFX or NF-Y alone. Promoter mutations that abolish formation of the RFX/NF-Y complex (M3, M4, and -17) lead to a strong reduction in promoter activity (up to 20-fold), whereas mutations that have no effect on its formation (Ml and -10) show no reduction in promoter activity. More importantly, a mutation that strongly reduces binding of RFX alone (>20-fold) but has only a modest effect (30% reduction) on the RFX/NF-Y complex (M2) maintains up to 40-75% of its activity. For the -17 mutation, reduction in promoter activity may also be due in part to disruption of the X2 box. However, this is unlikely to account entirely for the strong 80% reduction observed, because mutations of the DRA X2 box, including X2M (data not shown), do generally not have such a strong effect on promoter strength (21, 23) .
The effects of X-Y box spacing mutations on promoter activity and stability of the RFX/NF-Y complex correlate well for the -10, -5 and +5 constructs (Fig. 6C) . The -10 mutation, which reduces X-Y box spacing by one complete helical turn and hence does not alter stereospecific alignment between RFX and NF-Y, affects neither the RFX/NF-Y complex nor the activity of the promoter. The -5 and +5 mutations, which alter spacing by a half turn and thus affect alignment between RFX and NF-Y, reduce stability of the RFX/NF-Y complex and, as expected, inactivate the promoter. Alignment between RFX and NF-Y is thus an important parameter in determining RFX/NF-Y complex stability as well as promoter activity. These results agree well with the observation that to maintain HLA-DRA promoter function, X-Y box spacing must be an integral number of turns of the DNA helix (29, 30) . However, stability of the RFX/NF-Y complex does not seem to be the only parameter determining activity of the promoter. Thus, the +10 mutation reduces stability of the RFX/NF-Y complex to an extent similar to that observed for the -5 and +5 mutations, yet it enhances activity of the promoter (Fig. 6C ). This suggests that correct stereospecific alignment of RFX and NF-Y is more important than stability of the RFX/NF-Y complex.
How alignment between RFX and NF-Y affects activity is not clear. Incorrect alignment could have a direct effect on activation by altering the conformation of the RFX/NF-Y complex, or it could hinder binding of other proteins such as those recognizing the X2 box. Alternatively, correct alignment in the RFX/NF-Y complex may be essential for interactions with non-DNA-binding proteins required for promoter function. There is in fact evidence for the latter; in the regulatory mutants RJ2.2.5 and other members of the same complementation group (38, 39) , MHC class II promoters are silent although all of the known promoter-binding complexes, including RFX, NF-Y, and RFX/NF-Y, are detected normally in vitro (20, 40, 41) and the promoter is occupied in vivo (32) . This suggests that promoter occupancy is by itself not sufficient to activate transcription and that additional non-DNAbinding proteins are required. In fact, the protein responsible for the defect in these mutants has been cloned recently and does not bind directly to the MHC class II promoter (42) . This protein may well function indirectly via preformed protein complexes such as RFX/NF-Y assembled at the promoter.
Proteins binding to the X2 box are not involved in RFX/ NF-Y complex formation (Fig. 4D) , but X2-binding proteins are capable of interacting with RFX. We have in fact obtained evidence that RFX can also bind cooperatively with X2-binding proteins (unpublished data). RFX thus appears to be a central player in cooperative interactions between MHC class II promoter-binding proteins. This may provide an explanation for the bare-promoter phenotype observed in CID cells, in which the only detectable binding defect concerns RFX (18) (19) (20) . In vivo occupation of the X2 and Y boxes by X2-binding proteins and NF-Y may require cooperative binding with RFX.
